Joseph Aisner
Impact in
- Oncology top 0.2%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Occupational and environmental lung diseases
Papers in
- Oncology 161
- Lung Cancer Research Studies 63
- Cancer Treatment and Pharmacology 47
- Neutropenia and Cancer Infections 26
-
- Lung Cancer Treatments and Mutations 53
- Lung Cancer Diagnosis and Treatment 33
- Occupational and environmental lung diseases 17
- Co-authors
- Peter H. Wiernik (45 shared papers)Margaret Whitacre (23 shared papers)Merrill J. Egorin (21 shared papers)David A. Van Echo (34 shared papers)Charles A. Schiffer (22 shared papers)Bruce E. Johnson (2 shared papers)Wiernik Ph (18 shared papers)Richard Stephens (1 shared paper)
- Journals
- Journal of Clinical Oncology (39 papers)Cancer Chemotherapy and Pharmacology (17 papers)Cancer (13 papers)International Journal of Radiation Oncology*Biology*Physics (9 papers)Transfusion (8 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Joseph Aisner
302 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Oncology 5.2k
- Pulmonary and Respiratory Medicine 3.9k
- Hematology 934
- Epidemiology 2.4k
- Biochemistry 415
Countries citing papers authored by Joseph Aisner
This map shows the geographic impact of Joseph Aisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Aisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Aisner more than expected).
Fields of papers citing papers by Joseph Aisner
This network shows the impact of papers produced by Joseph Aisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Aisner. The network helps show where Joseph Aisner may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph Aisner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission Hit paper breakdown → | 1999 | 1155 |
| 2 | Treatment of Invasive Aspergillosis: Relation of Early Diagnosis and Treatment to Response Hit paper breakdown → | 1977 | 344 |
| 3 | Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function. | 1984 | 258 |
| 4 | 1979 | 228 | |
| 5 | 1976 | 175 | |
| 6 | 2000 | 174 | |
| 7 | 1997 | 167 | |
| 8 | 2010 | 158 | |
| 9 | Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum. | 1985 | 155 |
| 10 | 2007 | 147 | |
| 11 | 2001 | 139 | |
| 12 | 1992 | 129 | |
| 13 | 2007 | 127 | |
| 14 | 1982 | 125 | |
| 15 | Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. | 1983 | 116 |
| 16 | 1993 | 113 | |
| 17 | Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. | 1982 | 107 |
| 18 | 2002 | 103 | |
| 19 | 1981 | 102 | |
| 20 | 1997 | 101 |
About Joseph Aisner
Joseph Aisner is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Hematology, having authored 308 papers that have together received 10.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (63 papers), Lung Cancer Treatments and Mutations (53 papers), Cancer Treatment and Pharmacology (47 papers), Neuroendocrine Tumor Research Advances (39 papers), Cancer therapeutics and mechanisms (35 papers), Lung Cancer Diagnosis and Treatment (33 papers), Neutropenia and Cancer Infections (26 papers) and Occupational and environmental lung diseases (17 papers). The work is most often cited by research in Oncology (5.2k citations), Pulmonary and Respiratory Medicine (3.9k citations), Hematology (934 citations), Epidemiology (2.4k citations) and Biochemistry (415 citations). Joseph Aisner has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Peter H. Wiernik, Margaret Whitacre, Merrill J. Egorin, David A. Van Echo, Charles A. Schiffer, Bruce E. Johnson, Wiernik Ph, Richard Stephens, Hiroshi Ueoka and Henry Wagner. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer, International Journal of Radiation Oncology*Biology*Physics and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.